- Home
- GASS vs AVIR Comparison
GASS vs AVIR Comparison
Compare GASS & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GASS | AVIR |
|---|---|---|
| Founded | 2004 | 2012 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 291.3M | 266.4M |
| IPO Year | 2005 | 2020 |
Fundamental Metrics
Financial Performance| Metric | GASS | AVIR |
|---|---|---|
| Price | $8.05 | $4.11 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 113.2K | ★ 520.9K |
| Earning Date | 02-20-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.66 | N/A |
| Revenue | ★ $177,257,115.00 | N/A |
| Revenue This Year | $5.86 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $4.85 | ★ N/A |
| Revenue Growth | ★ 12.23 | N/A |
| 52 Week Low | $4.90 | $2.46 |
| 52 Week High | $8.18 | $4.34 |
Technical Indicators
Market Signals| Indicator | GASS | AVIR |
|---|---|---|
| Relative Strength Index (RSI) | 66.91 | 62.12 |
| Support Level | $7.56 | $3.75 |
| Resistance Level | $8.00 | $4.31 |
| Average True Range (ATR) | 0.24 | 0.24 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 72.06 | 76.51 |
Price Performance
Historical ComparisonAbout GASS StealthGas Inc.
StealthGas Inc is an international shipping transportation company. It owns liquefied petroleum gas (LPG) pressurized carriers and provides international seaborne transportation services to LPG producers and users, as well as crude oil and product carriers to oil producers, refineries, and commodities traders. The company carriers carry various petroleum gas products in liquefied forms, such as propane, butane, butadiene, isopropane, propylene, and vinyl chloride monomer, which are all byproducts of the production of crude oil and natural gas.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).